EMA head Rasi proposes scientific committees co-ordinating group; timings between PRAC and CHMP meetings questioned
This article was originally published in SRA
Executive Summary
European Medicines Agency head Guido Rasi has proposed setting up a new group charged with improving co-ordination between the agency's various scientific committees, the seventh of which – the important Pharmacovigilance Risk Assessment Committee – is to hold its inaugural meeting in July.